Article Information
History
- September 6, 2024.
Article Versions
- Version 1 (March 26, 2024 - 09:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Phyllis M. Thangaraj1,*,
- Sumukh Vasisht Shankar1,*,
- Sicong Huang3,
- Girish N. Nadkarni4,5,
- Bobak J. Mortazavi3,
- Evangelos K. Oikonomou1 and
- Rohan Khera1,2,6,7,*
- 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- 2Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, CT
- 3Department of Computer Science and Engineering, Texas A&M University, College Station, TX
- 4The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 5The Division of Data Driven and Digital Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 6Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT
- 7Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
- ↵*Address for correspondence: Rohan Khera, MD, MS, 195 Church St, 6th Floor, New Haven, CT 06510, 203-764-5885; rohan.khera{at}yale.edu; @rohan_khera
↵* Contributed Equally
Posted September 06, 2024.
A Novel Digital Twin Strategy to Examine the Implications of Randomized Clinical Trials for Real-World Populations
